Skip to main content
. 2021 Jan 19;12(2):106–124. doi: 10.18632/oncotarget.27866

Figure 1. The impact of iron chelators on the hallmarks of cancer.

Figure 1

Iron chelators have been shown to reverse many oncogenic signalling pathways associated with each hallmark of cancer with NDRG1 being a common thread. Generated through BioRender.com [47, 48].